Cysteine chloromethyl and diazomethyl ketone derivatives with potent anti-leukemic activity.
暂无分享,去创建一个
[1] F. Uckun,et al. Rational Design and Synthesis of a Novel Anti-leukemic Agent Targeting Bruton′s Tyrosine Kinase (BTK), LFM-A13 [α-Cyano-β-Hydroxy-β-Methyl-N-(2,5-Dibromophenyl)Propenamide]* , 1999, The Journal of Biological Chemistry.
[2] N. Heerema,et al. Clinical significance of MLL-AF4 fusion transcript expression in the absence of a cytogenetically detectable t(4;11)(q21;q23) chromosomal translocation. , 1998, Blood.
[3] H. Sather,et al. Augmented post-induction therapy for children with high-risk acute lymphoblastic leukemia and a slow response to initial therapy. , 1998, The New England journal of medicine.
[4] X. P. Liu,et al. 4-(3'-Bromo-4'hydroxylphenyl)-amino-6,7-dimethoxyquinazoline: a novel quinazoline derivative with potent cytotoxic activity against human glioblastoma cells. , 1998, Clinical cancer research : an official journal of the American Association for Cancer Research.
[5] H. Sather,et al. Clinical features and treatment outcome of children with myeloid antigen positive acute lymphoblastic leukemia: a report from the Children's Cancer Group. , 1997, Blood.
[6] R. Rando,et al. Solubilization, partial purification, and affinity labeling of the membrane-bound isoprenylated protein endoprotease. , 1996, Biochemistry.
[7] A. Burkhardt,et al. Biotherapy of B-cell precursor leukemia by targeting genistein to CD19-associated tyrosine kinases , 1995, Science.
[8] F. Uckun,et al. Sensitivity of primary clonogenic blasts from acute lymphoblastic leukemia patients to an activated cyclophosphamide, viz., mafosfamide. , 1994, Leukemia & lymphoma.
[9] F. Uckun,et al. Pretransplantation burden of leukemic progenitor cells as a predictor of relapse after bone marrow transplantation for acute lymphoblastic leukemia. , 1993, The New England journal of medicine.
[10] C. Poulter,et al. Prenylated proteins. A convenient synthesis of farnesyl cysteinyl thioethers , 1991 .
[11] E. Shaw,et al. Peptidyl diazomethyl ketones are specific inactivators of thiol proteinases. , 1981, The Journal of biological chemistry.